Cancer Gene Therapy - Table of Contents alert Volume 16 Issue 2

TABLE OF CONTENTS Volume 16, Issue 2 (February 2009) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement NPG announces a free website for biology classes... Scitable by Nature Education Scitable is designed to expand students' knowledge of genetics by providing expert, evidence-based content. To learn more about this exciting, new educational product visit online.   Advance Online Publication Articles for this journal are published online ahead of print through Advance Online Publication (AOP), meaning that the latest research reaches you in the timeliest way possible. Check the AOP webpage each week to make sure that you are not left behind.   Review Top Transcription factors: their potential as targets for an individualized therapeutic approach to cancer C Mees, J Nemunaitis & N Senzer Cancer Gene Ther 2009 16: 103-112; advance online publication, October 10, 2008; 10.1038/cgt.2008.73 Abstract | Full Text Original Articles Top Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo M-S Song, J-S Jeong, G Ban, J-H Lee, Y-S Won, K-S Cho, I-H Kim & S-W Lee Cancer Gene Ther 2009 16: 113-125; advance online publication, August 29, 2008; 10.1038/cgt.2008.64 Abstract | Full Text E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer K Fukuda, M Abei, H Ugai, R Kawashima, E Seo, M Wakayama, T Murata, S Endo, H Hamada, I Hyodo & K K Yokoyama Cancer Gene Ther 2009 16: 126-136; advance online publication, September 26, 2008; 10.1038/cgt.2008.67 Abstract | Full Text Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer L P Lefter, S Dima, M Sunamura, T Furukawa, Y Sato, M Abe, M Chivu, I Popescu & A Horii Cancer Gene Ther 2009 16: 137-148; advance online publication, September 5, 2008; 10.1038/cgt.2008.65 Abstract | Full Text TNF- and the IFN--inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma M Enderlin, E V Kleinmann, S Struyf, C Buracchi, A Vecchi, R Kinscherf, F Kiessling, S Paschek, S Sozzani, J Rommelaere, J J Cornelis, J Van Damme & C Dinsart Cancer Gene Ther 2009 16: 149-160; advance online publication, August 1, 2008; 10.1038/cgt.2008.62 Abstract | Full Text PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts J J Parry, V Sharma, R Andrews, E G Moros, D Piwnica-Worms & B E Rogers Cancer Gene Ther 2009 16: 161-170; advance online publication, August 29, 2008; 10.1038/cgt.2008.70 Abstract | Full Text Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo M P Rubinstein, M L Salem, A N Kadima, C L Nguyen, W E Gillanders, M I Nishimura & D J Cole Cancer Gene Ther 2009 16: 171-183; advance online publication, August 8, 2008; 10.1038/cgt.2008.63 Abstract | Full Text Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV D T Ho, S Wykoff-Clary, C S Gross, D Schneider, F Jin, P J Kretschmer & T W Hermiston Cancer Gene Ther 2009 16: 184-194; advance online publication, August 29, 2008; 10.1038/cgt.2008.68 Abstract | Full Text Advertisement Announcing an open access option in British Journal of Cancer. An open access option is now available to all authors of original research papers that are accepted for publication in BJC. BJC OPEN articles will be freely accessible to all readers immediately on publication. Learn more about BJC OPEN by visiting BJC online at www.bjcancer.com.   More Nature Products More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2009 Nature Publishing Group